We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

100 hedge funds and large institutions have $1.07B invested in Heron Therapeutics in 2017 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 49 increasing their positions, 15 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

227% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 15

56% more capital invested

Capital invested by funds: $690M → $1.07B (+$385M)

50% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 16

1% more funds holding

Funds holding: 99 → 100 (+1)

0.64% less ownership

Funds ownership: 134.39% → 133.75% (-0.64%)

19% less call options, than puts

Call options by funds: $1.36M | Put options by funds: $1.68M

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

Holders
100
Holders Change
+1
Holders Change %
+1.01%
% of All Funds
2.49%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.1%
New
24
Increased
49
Reduced
15
Closed
16
Calls
$1.36M
Puts
$1.68M
Net Calls
-$323K
Net Calls Change
-$13M

Top Buyers

1
BlackRock
BlackRock
New York
+$36.7M
2
TCM
Tang Capital Management
California
+$34M
3
Invesco
Invesco
Georgia
+$31.9M
4
CC
Carlson Capital
Texas
+$30.5M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$29.9M

Top Sellers

1
CAM
Cormorant Asset Management
Massachusetts
-$10.4M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$6.73M
3
VMI
VHCP Management II
New York
-$5.32M
4
Millennium Management
Millennium Management
New York
-$3.37M
5
EAM
Eventide Asset Management
Massachusetts
-$2.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
51
Bank of America
North Carolina
$815K +$39.2K +2,834 +6%
RhumbLine Advisers
52
RhumbLine Advisers
Massachusetts
$666K +$135K +9,778 +28%
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
$611K +$78.9K +5,701 +16%
Wells Fargo
54
Wells Fargo
California
$595K +$241K +17,442 +79%
SCA
55
Secor Capital Advisors
New York
$594K +$549K +39,629 New
Citigroup
56
Citigroup
New York
$577K -$2.44M -176,173 -82%
Russell Investments Group
57
Russell Investments Group
United Kingdom
$532K +$491K +35,506 New
FPC
58
Falcon Point Capital
California
$501K +$462K +33,379 New
PPA
59
Parametric Portfolio Associates
Washington
$497K +$213K +15,394 +87%
OPPM
60
Opus Point Partners Management
New York
$476K +$439K +31,748 New
VRS
61
Virginia Retirement Systems
Virginia
$459K +$424K +30,600 New
D.E. Shaw & Co
62
D.E. Shaw & Co
New York
$439K +$209K +15,132 +107%
MFIMFI
63
Mesirow Financial Investment Management - Fixed Income
Illinois
$435K +$402K +29,010 New
MLICM
64
Metropolitan Life Insurance Company (MetLife)
New York
$424K +$30.9K +2,233 +9%
Manulife (Manufacturers Life Insurance)
65
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$399K +$70.6K +5,098 +24%
AIG
66
American International Group
New York
$380K +$97.7K +7,059 +39%
SC
67
Searle & Co
Connecticut
$353K +$325K +23,500 New
NFA
68
Nationwide Fund Advisors
Ohio
$330K +$30.9K +2,233 +11%
Norges Bank
69
Norges Bank
Norway
$300K +$277K +20,000 New
State Board of Administration of Florida Retirement System
70
State Board of Administration of Florida Retirement System
Florida
$253K – – –
Tudor Investment Corp
71
Tudor Investment Corp
Connecticut
$253K +$234K +16,894 New
VKH
72
Virtu KCG Holdings
New York
$231K -$205K -14,846 -49%
HighTower Advisors
73
HighTower Advisors
Illinois
$225K – – –
VOYA Investment Management
74
VOYA Investment Management
Georgia
$212K +$12.4K +899 +7%
OWIM
75
Old West Investment Management
California
$206K +$191K +13,765 New
1 2
3
4 5

HRTX Hedge Fund Activity: Q1 2017 in Review

100 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q1 2017, worth a combined $1.07B — up 56% from $690M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new HRTX positions and 16 closed out — a net gain of 8 holders — while 49 added to existing stakes and 15 trimmed.

The largest buyer was BlackRock, adding an estimated $36.7M. The largest seller was Cormorant Asset Management, cutting an estimated $10.4M.

  • 100 institutional investors held Heron Therapeutics (HRTX) as of Q1 2017, up from 99 in Q4 2016.
  • Funds reported $1.07B of Heron Therapeutics stock for Q1 2017, up 56% quarter-over-quarter.
  • 24 funds opened new Heron Therapeutics positions in Q1 2017 and 16 closed out, a net change of +8 holders.
  • The largest Heron Therapeutics buyer in Q1 2017 was BlackRock, an estimated $36.7M added.
  • The largest Heron Therapeutics seller in Q1 2017 was Cormorant Asset Management, an estimated $10.4M sold.

Based on aggregated 13F filings for Q1 2017.